Vaccine Adjuvants

1. Microbial Pathogenesis and the Discovery of Toll-Like Receptor Function
Bruce Beutler

2. Dendritic Cells
Bali Pulendran, Anshu Agrawal, Stephanie Dillon, Sudhanshu Agrawal

3. Achieving Transcriptional Specificity in NF-?B-Dependent Inflammatory Gene Expression
Gioacchino Natoli

4. Adjuvants and the Initiation of T-Cell Responses
Matthew F. Mescher, Julie M. Curtsinger, Marc Jenkins

5. Mechanism for Recognition of CpG DNA
Kiyoshi Takeda, Hiroaki Hemmi, Shizuo Akira

6. CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines
Arthur M. Krieg, Heather L. Davis

7. Modified Bacterial Toxins
Ed C. Lavelle, Olive Leavy, Kingston H. G. Mills

8. Glycosylphosphatidylinositol Anchors As Natural Immunological Adjuvants Derived From Protozoan Parasites
Ricardo T. Gazzinelli, Catherine Ropert, Igor C. Almeida, João S. Silva, Marco A. Campos

9. The Immunomodulatory Glycan LNFPIII/Lewis X Functions As a Potent Adjuvant for Protein Antigens
Mitsuhiro Okano, Kazunori Nishizaki, Akram Da’dara, Paul Thomas, Michele Carter, Donald A. Harn

10. Immune and Antiviral Effects of the Synthetic Immunomodulator Murabutide
George M. Bahr

11. Effects of QS-21 on Innate and Adaptive Immune Responses
Charlotte Read Kensil, Gui Liu, Christine Anderson, James Storey

12. Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators
Jory Baldridge, Kent Myers, David Johnson, David Persing, Christopher Cluff, Robert Hershberg

13. Microparticles and DNA Vaccines
Kimberly Denis-Mize, Manmohan Singh, Derek T. O’Hagan, Jeffrey B. Ulmer, John J. Donnelly

DRM-restrictions

Printing: not available
Clipboard copying: not available

Avainsanat: TECHNOLOGY & ENGINEERING / Biomedical TEC059000